Literature DB >> 26597600

EMPA-REG - the "diuretic hypothesis".

John McMurray1.   

Abstract

Mesh：

Substances：

Year:  2015        PMID： 26597600     DOI： 10.1016/j.jdiacomp.2015.10.012

Source DB:  PubMed          Journal:  J Diabetes Complications        ISSN： 1056-8727            Impact factor:   2.852


× No keyword cloud information.
  28 in total

Review 1.  Effect of SGLT2 Inhibitors on the Sympathetic Nervous System and Blood Pressure.

Authors:  André J Scheen
Journal:  Curr Cardiol Rep       Date:  2019-06-21       Impact factor: 2.931

Review 2.  Implications of the CANVAS Study in Reducing Cardiovascular Outcomes.

Authors:  Ameena Madan Paramasivan; Archana Purushothaman; Cyrus Desouza
Journal:  Curr Diab Rep       Date:  2018-11-05       Impact factor: 4.810

Review 3.  SGLT2 inhibitors in the management of type 2 diabetes.

Authors:  R P Monica Reddy; Silvio E Inzucchi
Journal:  Endocrine       Date:  2016-06-07       Impact factor: 3.633

4.  Sodium-glucose cotransporter-2 inhibitors and cardiovascular outcomes: insights from the CVD-REAL study.

Authors:  Marwan Saad
Journal:  Ann Transl Med       Date:  2018-02

Review 5.  Implications of the EMPA-REG Trial for Clinical Care and Research.

Authors:  Angeliki M Stamatouli; Silvio E Inzucchi
Journal:  Curr Diab Rep       Date:  2016-12       Impact factor: 4.810

Review 6.  Sodium Glucose Cotransporter-2 Inhibition in Heart Failure: Potential Mechanisms, Clinical Applications, and Summary of Clinical Trials.

Authors:  Yuliya Lytvyn; Petter Bjornstad; Jacob A Udell; Julie A Lovshin; David Z I Cherney
Journal:  Circulation       Date:  2017-10-24       Impact factor: 29.690

Review 7.  Type 2 Diabetes and Thiazide Diuretics.

Authors:  André J Scheen
Journal:  Curr Diab Rep       Date:  2018-02-05       Impact factor: 4.810

Review 8.  Renal, metabolic and cardiovascular considerations of SGLT2 inhibition.

Authors:  Ralph A DeFronzo; Luke Norton; Muhammad Abdul-Ghani
Journal:  Nat Rev Nephrol       Date:  2016-12-12       Impact factor: 28.314

Review 9.  Heart failure - what's new and what's changed?

Authors:  Paul D Callan; Andrew L Clark
Journal:  Clin Med (Lond)       Date:  2016-12       Impact factor: 2.659

Review 10.  Heart failure - what's new and what's changed?

Authors:  Paul D Callan; Andrew L Clark
Journal:  Clin Med (Lond)       Date:  2017-07       Impact factor: 2.659
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.